Document type
ArticleVersion
Published versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/203294
Heparin: New life for an old drug
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
© 2017 Future Medicine Ltd. Heparin is one of the oldest drugs, which nevertheless remains in widespread clinical use as an inhibitor of blood coagulation. The history of its identification a century ago unfolded amid one of the most fascinating scientific controversies turning around the distribution of credit for its discovery. The composition, purification and structure-function relationship of this naturally occurring glycosaminoglycan regarding its classical role as anticoagulant will be dealt with before proceeding to discuss its therapeutic potential in, among other, inflammatory and infectious disease, cancer treatment, cystic fibrosis and Alzheimer's disease. The first bibliographic reference hit using the words 'nanomedicine' and 'heparin' is as recent as 2008. Since then, nanomedical applications of heparin have experienced an exponential growth that will be discussed in detail, with particular emphasis on its antimalarial activity. Some of the most intriguing potential applications of heparin nanomedicines will be exposed, such as those contemplating the delivery of drugs to the mosquito stages of malaria parasites.
Subject (English)
Citation
Collections
Citation
ALÁEZ VERSÓN, Carlos Raúl, LANTERO, Elena and FERNÀNDEZ BUSQUETS, Xavier. Heparin: New life for an old drug. Nanomedicine. 2017. Vol. 12, num. 14, pags. 1727-1744. ISSN 1748-6963. [consulted: 17 of August of 2026]. Available at: https://hdl.handle.net/2445/203294